May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Hidehito Horinouchi: Afatinib in patients with solid tumors with neuregulin1 (NRG1) fusions
Apr 15, 2025, 13:18

Hidehito Horinouchi: Afatinib in patients with solid tumors with neuregulin1 (NRG1) fusions

Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, posted on X:

“Afatinib in patients with solid tumors with neuregulin 1 fusions: a case series from the TAPUR Study.

Efficacy of afatinib in lung, colorectal, and pancreatic cancers harboring NRG1 fusions – Dr. Jordi Rodon.”

“Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.”

Authors: Jordi Rodon et al.

Hidehito Horinouchi: Afatinib in patients with solid tumors with neuregulin1 (NRG1) fusions